From Lab to Market: A Practical Guide to Commercializing Women's Health Innovation

October 15, 2026
Therapeutics, Diagnostics & Med Device Innovation

Designed for academic founders and early therapeutics, diagnostics and med device companies navigating the path from scientific validation to commercial scale.

In women's health, the person using your product and the person paying for it are rarely the same. Understanding that distinction and building your science, narrative, and commercial model around it is what separates a promising discovery from a fundable, scalable company.

This session covers:

•             What pre-seed investors need to see and what kills early deals

•             How technology transfer offices evaluate commercial potential

•             Why your user and your payer are rarely the same person -- and why that shapes everything from day one

•             How to build a narrative that connects your science to a fundable business

Speakers
Dr. Morag Grassie
Dr. Morag Grassie, Executive Director, Blavatnik Fund for Innovation - Yale